Clients reported gaps in basic information. The study team observed that limited knowledge, and specific misconceptions about PrEP versus antiretroviral therapy, reduced participants’ capability to make informed prevention decisions. Some men did not understand how daily prophylaxis differed from treatment for HIV; others underestimated their own risk. Investigators reported that these cognitive barriers operated before access issues, framing early attrition in the PrEP cascade. The qualitative data suggested that improving factual understanding is necessary but not sufficient: knowledge must be paired with strategies that address behavioural and social drivers.
Participants described social risks tied to PrEP use. Data indicated that HIV- and sexuality-related stigma, concerns about disclosure, and perceived social surveillance made PrEP use socially costly. Men feared being labeled as HIV-positive or having their sexual orientation exposed. Providers echoed these concerns, noting that clients weighed potential social harms when deciding whether to start or continue PrEP. The focus groups revealed that stigma operated both within families and in broader community settings, creating complex trade-offs between personal protection and social safety.
Distance and clinic logistics constrained opportunity. The cohort and providers identified travel distance, transport costs, incompatible work schedules, limited clinic hours, and the cumulative burden of frequent visits as barriers to initiation and retention. Conversely, investigators reported several pragmatic facilitators: provision of free care, brief clinic visits, appointment reminders, and multi-month dispensing reduced friction. The study team observed that flexible dispensing intervals and streamlined visits directly addressed physical opportunity constraints that commonly interrupt the PrEP cascade.
Daily dosing and variable sexual behaviour complicated persistence. Authors noted that taking a pill every day was challenging for some men; side effects and simple forgetfulness also reduced continued use. Several participants described periods of changing sexual activity that altered perceived need and adherence. The transcripts showed that establishing routines—coupled with reminders and acceptable PrEP modalities—supported continuation. The analysis suggested that adherence supports tailored to daily life patterns (for example, reminders timed to individual routines) could improve persistence without requiring intensive clinical resources.
Motivation to use PrEP rose when services felt safe. Investigators reported that non-judgmental, MSM-affirming care, high-quality counseling, and trusted provider relationships strengthened clients’ sense of safety, agency, and control. These emotional and relational factors translated into greater willingness to initiate and remain on PrEP. The study team observed that counselling that addressed both factual misunderstandings and concerns about disclosure, in a culturally competent manner, was a low-intensity adaptation likely to affect uptake and persistence.
This work drew on three focus groups with 16 HIV-negative MSM eligible for but not using PrEP, and six key informant interviews with providers at a single specialized clinic in Cape Town. The authors noted the small, qualitative sample and single-site design, which limit generalizability. They also indicated that full qualitative transcripts are not publicly available because of participant sensitivity and identification risk, though de-identified excerpts supporting findings are included in the manuscript. The study did not report quantified effect sizes, nor did it test specific interventions or dosing schedules; those methodological details were outside the scope of this qualitative analysis.
Concrete implementation questions remain. The source did not report operational details for scaling multi-month dispensing or the cost and workflow implications of expanded counselling and reminder systems. The study did not evaluate alternative PrEP modalities (beyond noting that acceptable modalities supported persistence) in comparative detail. Future work could test which low-intensity adaptations—tailored counseling content, timing and modality of reminders, and dispensing frequency—most effectively increase uptake and sustained use among diverse MSM populations in South Africa and comparable settings.